鉴定导致自身炎症的IL-1受体突变指导IL-1向药物设计
Yusha Wang1, Jun Wang2, Wenjie Zheng3
1Life Sciences Institute, Zhejiang University, Hangzhou 310058, Zhejiang, China; Liangzhu Laboratory, Zhejiang University, Hangzhou 311121, Zhejiang, China.
Immunity
|June 14, 2023
概括
一种新的IL-1R1变体通过破坏IL-1Ra结合导致自身炎症性疾病. 这项研究确定了IL-1驱动的炎症状况的新治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 类风湿病学 类风湿病学
背景情况:
- 介素-1 (IL-1) 途径在全身炎症和自身炎症性疾病中至关重要.
- 通过IL-1受体1型 (IL-1R1) 失调的IL-1信号传递有助于各种病理.
研究的目的:
- 为了研究患者与IL-1R1.1相关的慢性复发多焦点骨髓炎 (CRMO) 的分子基础.
- 阐明一种新型IL-1R1变异的功能后果,并探索治疗策略.
主要方法:
- 基因测序以识别IL-1R1.1.中的变异.
- 对患者外周血液单核细胞 (PBMC) 进行炎症特征分析.
- 在体外测试对对突变IL-1R1.1的联体结合的评估.
- 产生和分析具有同源IL-1R1突变的小鼠模型.
- 开发一种向IL-1治疗方法.
主要成果:
- 在CRMO患者中,在IL-1R1中发现了一个新的误解变体 (p.Lys131Glu).
- 替代p.Lys131Glu损害了IL-1受体对抗剂 (IL-1Ra) 的结合,导致无阻碍的IL-1信号传递.
- 患者的PBMCs在单细胞和中性粒细胞中表现出较高的炎症标志物.
- 具有同源突变的小鼠表现出高炎症,增加对关节炎的易感性和骨质细胞形成.
- 设计了一种针对IL-1β和IL-1α的新型IL-1治疗向.
结论:
- IL-1R1 p.Lys131Glu变体破坏了IL-1Ra的对抗性,导致自身炎症性疾病.
- 这项研究提供了对IL-1驱动的炎症的机制性见解.
- 针对IL-1介导疾病,已开发出一种强效和特定的IL-1治疗策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


